Yahoo
LSE GBp

Worldwide Healthcare Ord (WWH.L)

393.50 +2.00 (+0.51%)
At close: October 30 at 4:35:10 PM GMT
Chart Range Bar
Loading chart for WWH.L
  • Previous Close 391.50
  • Open 391.00
  • Bid 391.00 x --
  • Ask 392.00 x --
  • Day's Range 389.86 - 396.00
  • 52 Week Range 322.52 - 418.47
  • Volume 1,176,051
  • Avg. Volume 1,259,588
  • Market Cap (intraday) 1.327B
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 15.74
  • EPS (TTM) 0.25
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.02 (0.61%)
  • Ex-Dividend Date Jun 11, 2026
  • 1y Target Est --

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap companies with a market capitalization of at least $5 billion. The fund employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Healthcare Index. The fund employs internal research to make its investments. It was formerly known as Finsbury Worldwide Pharmaceutical Trust plc. Worldwide Healthcare Trust PLC was formed in April 1995 and is domiciled in the United Kingdom.

www.worldwidewh.com

--

Full Time Employees

March 31

Fiscal Year Ends

Asset Management

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

WWH.L
4.80%
FTSE 100 (^FTSE)
8.04%

1-Year Return

WWH.L
8.71%
FTSE 100 (^FTSE)
9.94%

3-Year Return

WWH.L
36.43%
FTSE 100 (^FTSE)
46.43%

5-Year Return

WWH.L
7.12%
FTSE 100 (^FTSE)
48.25%

Analyst Insights

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    85.46%

  • Return on Assets (ttm)

    4.63%

  • Return on Equity (ttm)

    7.40%

  • Revenue (ttm)

    132.64M

  • Net Income Avi to Common (ttm)

    113.36M

  • Diluted EPS (ttm)

    0.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    70.82M

  • Total Debt/Equity (mrq)

    1.36%

  • Levered Free Cash Flow (ttm)

    28.64M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: